Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710)

Survival Benefit ◽

Locally Advanced ◽

Secondary Analysis ◽

Oncology Group ◽

Histological Features ◽

Re: Do Mixed Histological Features Affect Survival Benefit from Neoadjuvant Platinum-Based Combination Chemotherapy in Patients with Locally Advanced Bladder Cancer? A Secondary Analysis of Southwest Oncology Group-Directed Intergroup Study (S8710)

10.1016/j.juro.2012.03.067 ◽

2012 ◽

Vol 188 (1) ◽

pp. 72-72

Author(s):

David P. Wood

Keyword(s):

Bladder Cancer ◽

Survival Benefit ◽

Locally Advanced ◽

Secondary Analysis ◽

Oncology Group ◽

Histological Features ◽

DO MIXED HISTOLOGICAL FEATURES AFFECT SURVIVAL BENEFIT FROM NEOADJUVANT PLATINUM-BASED COMBINATION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER?

BJU International ◽

10.1111/j.1464-410x.2011.10582.x ◽

2011 ◽

Vol 108 (5) ◽

pp. 700-700 ◽

Cited By ~ 77

Author(s):

Emil Scosyrev ◽

Edward M. Messing

Keyword(s):

Bladder Cancer ◽

Survival Benefit ◽

Locally Advanced ◽

Histological Features ◽

DO MIXED HISTOLOGIC FEATURES AFFECT SURVIVAL BENEFIT FROM NEO-ADJUVANT PLATINUM-BASED COMBINATION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER?

BJU International ◽

10.1111/j.1464-410x.2010.10006.x ◽

2010 ◽

pp. no-no

Author(s):

Arjun V. Balar ◽

Matthew I. Milowsky

Keyword(s):

Bladder Cancer ◽

Survival Benefit ◽

Locally Advanced ◽

1708 DO MIXED HISTOLOGIC FEATURES AFFECT SURVIVAL BENEFIT FROM NEO-ADJUVANT PLATINUM-BASED COMBINATION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER?

10.1016/j.juro.2010.02.1555 ◽

2010 ◽

Vol 183 (4S) ◽

Author(s):

Edward Messing ◽

Emelian Scosyrev ◽

Benjamin Ely ◽

V.O. Speights ◽

H. Barton Grossman ◽

...

Keyword(s):

Bladder Cancer ◽

Survival Benefit ◽

Locally Advanced ◽

COMBINATION CISPLATIN, 5-FLUOROURACIL AND RADIATION THERAPY FOR LOCALLY ADVANCED UNRESECTABLE OR MEDICALLY UNFIT BLADDER CANCER CASES: A SOUTHWEST ONCOLOGY GROUP STUDY

10.1097/00005392-200101000-00014 ◽

2001 ◽

Vol 165 (1) ◽

pp. 56-61 ◽

Cited By ~ 45

Author(s):

MAHA H.A. HUSSAIN ◽

TRACY R. GLASS ◽

JEFFREY FORMAN ◽

WAEL SAKR ◽

DAVID C. SMITH ◽

...

Keyword(s):

Bladder Cancer ◽

Radiation Therapy ◽

Locally Advanced ◽

Oncology Group ◽

Oncology Group Study ◽

Southwest Oncology Group Study

The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: What we do not know and why

Annals of Oncology ◽

10.1023/a:1008399130226 ◽

2000 ◽

Vol 11 (7) ◽

pp. 851-856 ◽

Cited By ~ 79

Author(s):

R. Sylvester ◽

C. Sternberg

Keyword(s):

Bladder Cancer ◽

Locally Advanced ◽

Combination Chemotherapy with Intra-Arterial Cisplatin and Doxorubicin Plus Intravenous Methotrexate and Vincristine for Locally Advanced Bladder Cancer

10.1097/00005392-199511000-00030 ◽

1995 ◽

pp. 1704-1709

Author(s):

Seiji Naito ◽

Toshiro Kuroiwa ◽

Toyofumi Ueda ◽

Kanehiro Hasuo ◽

Kouji Masuda ◽

...

Keyword(s):

Bladder Cancer ◽

Locally Advanced ◽

Survival Benefit Persists With Delayed Initiation of Adjuvant Chemotherapy Following Radical Cystectomy for Locally Advanced Bladder Cancer

Urology ◽

10.1016/j.urology.2019.05.038 ◽

2019 ◽

Vol 132 ◽

pp. 143-149 ◽

Cited By ~ 1

Author(s):

Christopher J. Corbett ◽

Leilei Xia ◽

Ronac Mamtani ◽

Stanley Bruce Malkowicz ◽

Thomas J. Guzzo

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Radical Cystectomy ◽

Survival Benefit ◽

Locally Advanced ◽

Advanced Bladder Cancer ◽

Delayed Initiation

Combination Chemotherapy with Intra-Arterial Cisplatin and Doxorubicin Plus Intravenous Methotrexate and Vincristine for Locally Advanced Bladder Cancer

10.1016/s0022-5347(01)66759-4 ◽

1995 ◽

Vol 154 (5) ◽

pp. 1704-1709 ◽

Cited By ~ 6

Author(s):

Seiji Naito ◽

Toshiro Kuroiwa ◽

Toyofumi Ueda ◽

Kanehiro Hasuo ◽

Kouji Masuda ◽

...

Keyword(s):

Bladder Cancer ◽

Locally Advanced ◽

Combination Cisplatin and Dichloromethotrexate in Patients with Advanced Bladder Cancer. Phase 2. A Southwest Oncology Group Study

10.1016/s0022-5347(17)36506-0 ◽

1992 ◽

Vol 148 (1) ◽

pp. 52-54 ◽

Cited By ~ 4

Author(s):

Frederick J. Meyers ◽

Brent Blumenstein ◽

E. David Crawford ◽

Harry E. Hynes ◽

James E. Montie ◽

...

Keyword(s):

Bladder Cancer ◽

Phase 2 ◽

Oncology Group ◽

Oncology Group Study ◽

Advanced Bladder Cancer ◽

Southwest Oncology Group Study